Episode 80: Patients Need Checkpoint Inhibitor Education
This episode was supported by funding from Bristol-Myers Squibb Company.
ONS member Laura Wood, RN, MSN, OCN®, renal cancer research coordinator at the Cleveland Clinic Cancer Center in Ohio and member of the Cleveland ONS Chapter, joins Chris Pirschel, ONS staff writer/producer, to discuss patient education for immune checkpoint inhibitors, overcoming communication barriers, and the best strategies for successful patient education.
Episode Notes
Check out these resources from today’s episode:
- The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.
- Resources Are Available to Guide Management of Immunotherapy-Related Adverse Events
- Common Terminology Criteria for Adverse Events (CTCAE)
- Using CTCAE to Report Immunotherapy Adverse Events
- Immune Checkpoint Inhibitor Therapy: Key Principles When Educating Patients
- About Immunotherapy
- Management of Immunotherapy-Related Toxicities
- Society for Immunotherapy of Cancer
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Listen on:
Listen on Amazon Music, Listen on Apple Podcasts, Listen on Google Podcasts, Listen on Spotify, Listen on Stitcher